New York, NY -- (SBWIRE) -- 12/05/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: General Motors Company (NYSE:GM), Janus Capital Group Inc (NYSE:JNS), Generex Biotechnology Corporation (OTCMKTS:GNBT), Blue Water Global Group Inc (OTCBB:BLUU)
General Motors Company (NYSE:GM) showed a volume of 39.73 million shares by the end of last trade whereas the average volume of the stock remained 22.44 million shares. The stock opened the session at $38.53 but then moved to $38.71. At that price, the stock showed a positive performance of 1.49%. General Motors Corporation (General Motors) designs, build and sell cars, trucks and automobiles parts globally. The Company also provides automotive financing services through General Motors Financial Company, Inc. (GM Financial). The Company's automotive operations meet the demands of the Company's customers through its four automotive segments: GM North America (GMNA), GM Europe (GME), GM International Operations (GMIO) and GM South America (GMSA).
Will GM Continue To Move Higher? Find Out Here
Janus Capital Group Inc (NYSE:JNS) opened the session at $10.56 and closed the session at $10.82. The stock showed a positive performance of 2.37% in previous trading session. Traded with volume of 2.86 million shares in the prior session and the average volume of the stock remained 2.78 million shares. Janus Capital Group Inc., and its subsidiaries (JCG) provide investment management, administration, distribution and related services to financial advisors, individuals and institutional clients through mutual funds, other pooled investment vehicles, separate accounts and sub advised relationships (collectively referred to as investment products) in both domestic and international markets.
For How Long JNS will fight for Profitability? Read This Trend Analysis report
Generex Biotechnology Corporation (OTCMKTS:GNBT) opened the session at $0.03 and closed the session at $0.0310. The stock showed a negative performance of -4.62% in previous trading session. Traded with volume of 4.80 million shares in the prior session and the average volume of the stock remained 1.73 million shares. The beta of the stock remained 2.13. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world. The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Blue Water Global Group Inc (OTCBB:BLUU) the stock advanced 23.17% and finished the session at $0.0101. Traded with volume of 8.70 million shares in the prior session and the average volume of the stock remained 152,397.00 shares. Blue Water Global Group, Inc. (Blue Water) is a development-stage company. The Company focuses on developing a chain of casual dining restaurants in tourist destinations throughout the Caribbean region. The Company's initial restaurant is going to be called Blue Water Bar & Grill and will be located in St. Maarten, Dutch West Indies. As of February 7, 2013, the Company did not operate any restaurant properties, and did not have any ownership or leaseholds in any restaurant properties.
Will BLUU Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)